This is an old revision of this page, as edited by Innerstream (talk | contribs) at 22:38, 3 January 2025 (new page). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 22:38, 3 January 2025 by Innerstream (talk | contribs) (new page)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff) Pharmaceutical compoundIdentifiers | |
---|---|
IUPAC name
| |
CAS Number | |
PubChem CID | |
DrugBank | |
UNII | |
Chemical and physical data | |
Formula | C27H29ClN6O5 |
Molar mass | 553.02 g·mol |
3D model (JSmol) | |
SMILES
| |
InChI
|
Allisartan isoproxil is an antihypertensive pharmaceutical drug. It belongs to the angiotensin II receptor blocker class of drugs. It is an esterified prodrug, and its metabolism results in the formation of a single metabolite, losartan carboxylic acid (EXP3174), an oxidized form of losartan.
In China, allisartan isoproxil was approved by the Chinese Food and Drug Administration for the treatment of hypertension in 2012, and introduced to the market in 2013.
References
- . PMID 30896643.
{{cite journal}}
: Cite journal requires|journal=
(help); Missing or empty|title=
(help) - . PMID 38903964.
{{cite journal}}
: Cite journal requires|journal=
(help); Missing or empty|title=
(help) - . PMID 37343187.
{{cite journal}}
: Cite journal requires|journal=
(help); Missing or empty|title=
(help) - . PMC 11187348 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11187348.
{{cite journal}}
: Cite journal requires|journal=
(help); Missing or empty|title=
(help) - . doi:10.1038/s41401-021-00684-7.
{{cite journal}}
: Cite journal requires|journal=
(help); Missing or empty|title=
(help)